Edward Dyson

Partner

Londra

Ed counsels public and pre-IPO private companies, investors, entrepreneurs and underwriters on London Stock Exchange, Nasdaq and NYSE capital markets transactions.

He also regularly advises on domestic and cross-border public and private M&A deals, strategic ventures, direct listings/introductions, block trades, demergers/spin-outs, dual-listings, reverse mergers/takeovers, class and related party transactions, share buy-backs, transfers of listing segment and other corporate matters.

His broad industry experience includes working with companies in the energy, financial services, healthcare and life sciences, retail, media, natural resources and technology sectors.

  • Ed’s recent engagements include acting for:

    • VNV Global, as a major shareholder, on the Nasdaq de-SPACs of Swvl with Queen's Gambit Growth Capital and Gett with Rosecliff Acquisition Corp I
    • Kinnevik, as a major shareholder, on the Nasdaq de-SPAC of Babylon Health with Alkuri Global Acquisition
    • Heptares Therapeutics Limited, a wholly-owned subsidiary of Sosei Heptares Corporation, as a shareholder on the Nasdaq IPO of Centessa Pharmaceuticals plc
    • a selling shareholder on the Main Market IPO and standard listing of Deliveroo plc
    • Endava plc, a software development company, on its NYSE IPO
    • Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, on its demerger, AIM IPO and subsequent Nasdaq dual-listing
    • Kistos plc, a SPAC focused on energy transition, on its AIM IPO and subsequent reverse takeover of Tulip, associated placing, PrimaryBid offer, subscription and Norwegian listed bond offering
    • National World plc, a SPAC focused on news publishing, on its Main Market IPO and Standard listing, and subsequent reverse takeover of JPI Media and associated convertible loan note offering
    • Tiziana Life Sciences plc, a clinical-stage biopharmaceutical company, on its Nasdaq dual-listing and various global follow-on securities offerings
    • the underwriters on the Nasdaq IPO of Compass Pathways plc, a mental healthcare company
    • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, on its Nasdaq IPO and various follow-on securities offerings
    • Scancell Holdings plc, a clinical-stage biopharmaceutical company, on various AIM follow-on securities offerings
    • the underwriters on the aborted Nasdaq IPO of Horizon Discovery plc, an AIM-listed gene editing company
    • the underwriters on the Nasdaq IPO of Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company
    • Realm Therapeutics plc, a clinical-stage biopharmaceutical company, on its direct dual-listing on Nasdaq, subsequent AIM delisting and acquisition by Essa Pharma Inc. by way of scheme of arrangement
    • the underwriters on the aborted Nasdaq IPO of Kymab Limited, a clinical-stage biopharmaceutical company
    • the underwriters on various Nasdaq follow-on securities offerings by NuCana plc, a clinical-stage biopharmaceutical company
    • the underwriters on the aborted Nasdaq IPO of Mereo BioPharma Group plc, a clinical-stage biopharmaceutical company
    • RockRose Energy plc, an independent oil and gas company, on its readmission to the Main Market and Standard listing following the acquisition of the North Sea interests from Marathon Oil
    • OKYO Pharma Limited, a pre-clinical biopharmaceutical company, on its Main Market IPO and Standard listing, and associated equity placing and warrant issuance
    • MightyHive Inc., a data and digital media consultancy, on its acquisition by S4 Capital plc, a digital advertising and marketing company
    • Misys plc, a software company, on its aborted Main Market IPO and Premium listing
    • Just Retirement Group plc, a retirement financial solutions provider, on its standby underwritten follow-on offering, associated merger with Partnership Assurance Group plc, a non-standard annuity provider, and Main Market introduction and Premium listing of the combined entity, Just Group plc
    • B&M European Value Retail S.A. (B&M Stores), a European variety goods value retailer, on its Main Market IPO and Premium listing
    • the underwriters on the Main Market IPO and Premium listing of Metro Bank plc, a UK challenger bank
    • TCS Group Holding plc (Tinkoff Credit Systems), a Russian challenger bank, on its Main Market IPO and Standard listing
    • Romgaz S.A., a Romanian natural gas producer and supplier, on its Main Market IPO and Standard listing
    • Selling shareholders and underwriters on numerous secondary sale block trades

    Please note: Ed's experience includes that prior to joining Orrick.